将妊娠期胰岛素抵抗的逆转与产后抑郁症联系起来
Minoli Vinoda Abeysekera1, Duan Ni1,2, Leah Gilbert3
1Nepean Hospital, Nepean Blue Mountains Local Health District, Sydney, NSW, Australia.
BMC medicine
|October 8, 2024
概括
产后抑郁症 (PPD) 可能与分娩后胰岛素抵抗和葡萄糖代谢的变化有关. 中枢神经系统中的这些代谢变化可能会影响神经递质,导致PPD中出现的情绪变化.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 精神病学是一个精神病学.
背景情况:
- 产后抑郁症 (PPD) 影响全球近20%的怀孕,原因尚不清楚.
- 风险因素包括遗传,荷尔蒙和心理社会触发因素.
- 孕期糖尿病 (GDM) 和胰岛素抵抗 (IR) 越来越多地与更高的PPD风险有关.
研究的目的:
- 提出一种新的模型,将产后代谢变化与PPD发展联系起来.
- 探索胰岛素抵抗和葡萄糖代谢在中枢神经系统 (CNS) 在PPD病变发生过程中的作用.
主要方法:
- 审查和综合关于PPD,GDM,胰岛素抵抗和中枢神经系统功能的现有研究.
- 假设一种机制涉及产后代谢重构及其对神经递质系统的影响.
主要成果:
- 产后胰岛素抵抗和改变葡萄糖代谢的解决可能会显著影响中枢神经系统功能.
- 这些代谢变化可能会破坏多巴胺和血清素通路,影响情绪调节.
结论:
- 拟议的模型表明产后代谢变化是PPD的潜在病因因素.
- 验证这一假设可以为未来的PPD预防,诊断和治疗策略提供信息.
相关概念视频
Pathophysiology of Diabetes
881
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
881
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Glucagon-like Receptor Agonists
301
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
301
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K


